Indications for GnRH agonists in an in vitro fertilization program.
Diedrich
K
K
Department of Obstetrics and Gynecology, University of Bonn, Germany.
Schmutzler
R
R
D000728:Androgens / Q000378:metabolism; D000818:Animals; D004305:Dose-Response Relationship, Drug; D005260:Female; D005307:Fertilization in Vitro / Q000379:methods*; D007987:Gonadotropin-Releasing Hormone / Q000502:physiology*; D006062:Gonadotropins / Q000378:metabolism / Q000627:therapeutic use; D006801:Humans; D007246:Infertility / Q000378:metabolism / Q000628:therapy; D008596:Menotropins / Q000627:therapeutic use; D010053:Ovary / Q000187:drug effects; D010902:Pituitary Gland / Q000187:drug effects
D000728:Androgens; D006062:Gonadotropins; D007987:Gonadotropin-Releasing Hormone; D008596:Menotropins